La Roche-Posay Serozinc Zinc Sulfate Solution 150ml

SKU: 11271939

In-store pricing may vary by store. La Roche-Posay Serozinc is a purifying, soothing & mattifying toner mist with zinc sulphate to target the key signs of oily, acne-prone & irritated skin.

Read More
$27.99
4 x $7.00 with
Available for Purchase In-Store Only

Delivery_Stamp_1d12b3a0-3503-4eb2-8782-7011e0d86c35 Delivery_Stamp_1d12b3a0-3503-4eb2-8782-7011e0d86c35

You will earn 28 Living Rewards points per item with this purchase Login or Sign Up

Sorry, this item is currently out of stock
Secure and trusted checkout with
payment badge payment badge payment badge payment badge payment badge payment badge
Sorry, this item is not available for purchase
  • A purifying soothing & mattifying toner mist containing zinc sulphate and sodium chloride. Specially designed to target the key signs of oily acne-prone & irritated skin. Sodium chloride cleanses and tightens the pores whilst zinc sulphate help to reduce grease and mattify skin for a shine-free finish. Fragrance-free preservative-free hypoallergenic.

    La Roche-Posay Serozinc is a purifying, soothing & mattifying toner mist with zinc sulphate to target the key signs of oily, acne-prone & irritated skin.


  • All reasonable efforts have been made to ensure that ingredient listings for products displayed on this website are up to date accurate and complete. Please check ingredient listings for products before use or check instore. Purified Water - Sodium Chloride - Zinc Sulphate (FIL CODE: B2143/1)

  • This product has a purchase limit of 0. If the limit is 0, there is no restriction on the quantity you can purchase.

Care & Advice Health Hub
Our new Care & Advice Health Hub offers a wide range of essential services, from general health checks to specialised consultations.
Dont miss these bargains!
Check out our latest catalogue!
06410_-_Flu_campaign_-_Web_Life_3x1_specials_card_880x880_f3018824-2b68-472b-b7de-d874adbd8acd
Protect against the Flu this season!
Choose from three different Flu Vaccinations in 2025.